Design, synthesis and biological evaluation of a 4,6-di(aziridin-1-yl)-1,3,5-triazine–benzimidazole hybrid as a potential dual-targeting anticancer agent
Future Medicinal Chemistry · 19.05.2026 · 18 (10) · 1195-1210
DOI: 10.1080/17568919.2026.2658014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Future Medicinal Chemistry, online erschienen am 22.04.2026. Verfasst von Ivan S Chernov und 13 weiteren Autor:innen. Beteiligte Einrichtung: Pavlov First Saint-Petersburg State Medical University, St. Petersburg, Russia. Hauptthemen laut MEDLINE: Antineoplastic Agents, Benzimidazoles, Drug Design, Triazines. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: State Program of the Ministry of Health.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pavlov First Saint-Petersburg State Medical University, St. Petersburg, Russia.
- Institute of Experimental Medicine, St. Petersburg, Russia.
- A.M. Granov Russian Research Centre for Radiology and Surgical Technologies, Saint Petersburg, Russia.
- N.N. Blokhin Russian Cancer Research Center, Moscow, Russia.
- Peoples' Friendship University of Russia (RUDN University), Moscow, Russia.
- Saint-Petersburg State University, St. Petersburg, Russia.
ORCID-Profile: Ivan S Chernov, Alexandra V Protas, Elena А Popova, Olga S Shemchuk, Natalia V Petukhova, Gulalek Babayeva, Valeria M Tretiakova, Vyacheslav E Bulakov, Olga V Mikolaichuk, Il'ya V Kornyakov, Vadim S Pokrovsky, Konstantin N Semenov, Vladimir V Sharoyko
Förderung
- State Program of the Ministry of Health
Zitieren
APA
Chernov, I. S., Protas, A. V., Popova, E. А., Shemchuk, O. S., Petukhova, N. V., Babayeva, G., Tretiakova, V. M., Bulakov, V. E., Kozhukhov, P. K., Mikolaichuk, O. V., Kornyakov, I. V., Pokrovsky, V. S., Semenov, K. N., & Sharoyko, V. V. (2026). Design, synthesis and biological evaluation of a 4,6-di(aziridin-1-yl)-1,3,5-triazine–benzimidazole hybrid as a potential dual-targeting anticancer agent. Future Medicinal Chemistry, 18(10), 1195-1210. https://doi.org/10.1080/17568919.2026.2658014
Vancouver
Chernov IS, Protas AV, Popova EА, Shemchuk OS, Petukhova NV, Babayeva G, et al. Design, synthesis and biological evaluation of a 4,6-di(aziridin-1-yl)-1,3,5-triazine–benzimidazole hybrid as a potential dual-targeting anticancer agent. Future Medicinal Chemistry. 2026;18(10):1195-1210. doi:10.1080/17568919.2026.2658014
BibTeX
@article{Chernov2026,
author = {Chernov, Ivan S and Protas, Alexandra V and Popova, Elena А and Shemchuk, Olga S and Petukhova, Natalia V and Babayeva, Gulalek and Tretiakova, Valeria M and Bulakov, Vyacheslav E and Kozhukhov, Pavel K and Mikolaichuk, Olga V and Kornyakov, Il'ya V and Pokrovsky, Vadim S and Semenov, Konstantin N and Sharoyko, Vladimir V},
title = {Design, synthesis and biological evaluation of a 4,6-di(aziridin-1-yl)-1,3,5-triazine–benzimidazole hybrid as a potential dual-targeting anticancer agent},
journal = {Future Medicinal Chemistry},
year = {2026},
volume = {18},
number = {10},
pages = {1195--1210},
doi = {10.1080/17568919.2026.2658014}
}
EUVIMED